Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
ObesityWeek®️ 2024 | Gan & Lee Pharmaceuticals Orally Presents Phase 2b Clinical Data for GZR18 Injection in Chinese Overweight and Obese Adults 2024-11-11 19:36
TB Alliance Joins Indonesia's High-Level Meeting on TB 2024-11-11 10:30
Late-Breaking Abstract! Alphamab Oncology Presented the Latest Clinical Data of Anti-HER2 bispecific ADC Subcutaneous Co-formulation JSKN033 at SITC 2024 2024-11-11 10:04
Alteogen enters into an Exclusive License Agreement to Develop and Commercialize Subcutaneous ENHERTU® Enabled by Alteogen's Hybrozyme™ Technology 2024-11-11 08:07
Henlius and SVAX Forge Strategic Partnership in the MENAT Market 2024-11-09 00:35
Mabwell Reveals Encouraging Pre-clinical Data of 7MW4811 at the 15th World ADC Conference 2024-11-08 22:00
Samsung Biologics earns ISO certifications in recognition of business excellence 2024-11-08 20:00
Dizal Submits New Drug Application to the U.S. FDA for Sunvozertinib in Treating Relapsed or Refractory Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations 2024-11-08 18:01
Harbour BioMed Announces Submission of IND Application for HBM9378/SKB378 in the Treatment of Chronic Obstructive Pulmonary Disease 2024-11-08 17:45
WuXi XDC Named Best CDMO Winner at 2024 World ADC Awards 2024-11-08 11:27
InxMed Presents Data regarding Potential Novel Way to Improve Therapeutic Window of ADC by Ifebemtinib and FIC ADC at 15th Annual World ADC 2024-11-08 10:40
Akeso Published Mechanism of Action for CLDN18.2/CD47 Bispecific Antibody AK132 for the First Time at SITC Annual Meeting 2024-11-08 08:20
Ascletis Announces Promising Results from a Phase I Study in Australia for First-in-Class Muscle-Preserving Weight Loss Drug Candidate ASC47 for the Treatment of Obesity 2024-11-07 19:30
Aditum Bio and Leads Biolabs Announce the Formation of Oblenio Bio to Develop a Tri-Specific T-Cell Engager for Autoimmune Disorders 2024-11-07 16:29
Fosun Attends CIIE for the Seventh Time - Guo Guangchang: Confident that China's High-Level Openness is a Historical Opportunity 2024-11-07 13:18
Approx. USD 4.0 M Invested in Product Development for NTDs - GHIT's First Investment in the Development of Diagnostics for Trachoma 2024-11-07 10:00
I-Mab Appoints Sean Fu, PhD, MBA, as Chief Executive Officer 2024-11-06 20:00
Minghui Pharmaceutical Announces Promising Initial Results from Phase I Clinical Trial of MHB039A, a Novel PD-1 x VEGF Bispecific Antibody, in Patients with Relapsed/Refractory Solid Tumors 2024-11-06 18:00
ASH 2024 | Results From Three Clinical Studies of Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax Selected for Presentations, Including an Oral Report 2024-11-06 16:09
ASH 2024 | Studies of Olverembatinib Selected for Presentations, Including an Oral Report, for the Seventh Consecutive Year 2024-11-06 15:56
1 13 14 15 16 17 423